Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT05621408

Attention Training Technique in Treatment of Anxiety and Depression in Coronary Heart Disease Patients

Led by Vestre Viken Hospital Trust · Updated on 2024-05-16

64

Participants Needed

2

Research Sites

107 weeks

Total Duration

On this page

Sponsors

V

Vestre Viken Hospital Trust

Lead Sponsor

O

Oslo University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Anxiety and depression are associated with work disability, lower participation rate in cardiac rehabilitation and unfavourable life style changes following a coronary heart disease (CHD) event. The prevalence of clinically significant symptoms of depression and anxiety in CHD patients has been estimated to 30-50%. Furthermore, depression and anxiety are associated with a significant increased risk of subsequent major adverse cardiovascular events and mortality in CHD patients. Psychological interventions for anxiety and depression in CHD patients have demonstrated small and uncertain effects of symptoms, and no effect on cardiovascular outcomes. Therefore, testing the effectiveness of specific psychological interventions that may affect central mechanisms for cardiovascular outcomes, has been requested. The Attention training (ATT) Study is a randomized controlled trial comparing group-attention training to wait-list control in 64 patients who experience significant anxiety and depression after a CHD event. It will also be explored whether reduction in psychological symptoms is correlated with changes in biological markers with a potential link to cardiovascular outcomes.

CONDITIONS

Official Title

Attention Training Technique in Treatment of Anxiety and Depression in Coronary Heart Disease Patients

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Established coronary heart disease as main somatic disease
  • Score of 8 or higher on either Hospital Anxiety and Depression Scale anxiety or depression subscale
  • Age between 18 and 65 years
  • Ability to understand and speak Norwegian
  • Willingness and ability to give informed consent
Not Eligible

You will not qualify if you...

  • Current or past neurological illness
  • Traumatic brain injury
  • Current alcohol or substance dependency disorders
  • Psychotic disorders
  • Bipolar disorders
  • Developmental disorders
  • Mental retardation
  • Cognitive impairment preventing informed consent or participation
  • Acute suicidality
  • Life expectancy less than 12 months
  • Concurrent psychological intervention for emotional distress
  • Antidepressant or anxiolytic medication started within the previous 8 weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Hospital of Vestfold

Tønsberg, Vestfold and Telemark County, Norway, 3103

Not Yet Recruiting

2

Vestre Viken Trust Drammen hospital

Drammen, Viken County, Norway, 3004

Actively Recruiting

Loading map...

Research Team

J

John Munkhaugen, MD,PhD

CONTACT

T

Toril Dammen, MD,PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here